IMMUNOlogical microenvironment in REctal Adenocarcinoma Treatment (IMMUNOREACT 1; NCT04915326): preliminary results on prediction of presence of nodal metastasis in early rectal cancer
Gaya Spolverato(University of Padua), Marco Scarpa(University of Padua), Salvatore Pucciarelli(Azienda Ospedale - Università Padova), Ignazio Castagliuolo(University of Padua), Melania Scarpa(University of Padua), Cesare Ruffolo(Ca' Foncello Hospital), Marco Massani(AULSS 2 Marca Trevigiana), Valentina Chiminazzo(University of Padua), Giacomo Sarzo(Ospedale Sant Antonio), Roberto Merenda(Ospedale Civile di Venezia), Matteo Fassan(University of Padua), Pierluigi Pilati(Istituto Oncologico Veneto), Alice Bressan(Ospedale Sant Antonio), Ottavia De Simoni(Istituto Oncologico Veneto), Giovanni Pirozzolo(Ottawa Hospital), Imerio Angriman, Giovanni Bordignon(AULSS 2 Marca Trevigiana), Andrea Porzionato(University of Padua), Anna Pozza(University of Padua), Francesco Marchegiani
Cited by 0
Related Papers
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
Reversal of Type 1 Hepatorenal Syndrome With the Administration of Midodrine and Octreotide
|Hepatology|1999|560
Toll-Like Receptor 2 Regulates Intestinal Inflammation by Controlling Integrity of the Enteric Nervous System
|Gastroenterology|2013|296
cT3N0 Rectal Cancer: Potential Overtreatment With Preoperative Chemoradiotherapy Is Warranted
|Journal of Clinical Oncology|2008|266